Blood products, vaccines and immunological products: South Korea exports and imports
HS 3002 · 사람의 피, 치료용ㆍ예방용ㆍ진단용으로 조제한 동물의 피, 면역혈청ㆍ그 밖의 혈액 분획물과 면역물품(생물공학적 방법에 따라 변성되거나 얻어진 것인지에 상관없다), 백신ㆍ독소ㆍ미생물 배양체(효모는 제외한다)와 이와 유사한 물품, 세포 배양체(변성된 것인지에 상관없다) · latest month: October 2026
In October 2026, South Korea exported $730.6 million of blood products, vaccines and immunological products (HS 3002), up 8.5% from September 2026 and up 32.9% from October 2025.
Over the 12 months to October 2026, exports of blood products, vaccines and immunological products (HS 3002) totalled $8.76 billion, up 18.1% from the 12 months before ($7.42 billion).
The largest destination over the 12 months to October 2026 was Switzerland ($1.38 billion, 15.8% of the total), followed by the United States and Hungary.
That was 85.4% of South Korea's exports under HS chapter 30 (pharmaceutical products) over the same 12 months.
Imports in October 2026 were $425.8 million (up 37.3% from October 2025), leaving a surplus of $304.8 million for the month.
Official description of HS 3002: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms(excluding yeasts) and similar products; cell cultures, whether or not modified.
Last 24 months
Subheadings under HS 3002
| Code | Product | Exports, 12 months | Share | vs 12 months before | October 2026 |
|---|---|---|---|---|---|
| 3002.12 | Antisera and other blood fractions | $315.8M | 3.6% | +5.0% | $49.8M |
| 3002.12.2000 | Antisera | $415K | 0.1% | -13.2% | $10K |
| 3002.12.3000 | Other blood fractions | $315.4M | 99.9% | +5.0% | $49.8M |
| 3002.13 | Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | $1.3M | 0.0% | -84.4% | $43K |
| 3002.14 | Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale | $5.26B | 60.1% | +31.2% | $404.9M |
| 3002.15 | Immunological products, put up in measured doses or in forms or packings for retail sale | $2.24B | 25.6% | +0.5% | $204.1M |
| 3002.41 | Vaccines for human medicine | $246.2M | 2.8% | -13.5% | $17.5M |
| 3002.42 | Vaccines for veterinary medicine | $40.7M | 0.5% | +4.0% | $3.5M |
| 3002.42.1000 | Vaccines against foot and mouth disease | $3.6M | 8.9% | – | $0 |
| 3002.42.9000 | Other | $37.1M | 91.1% | -5.3% | $3.5M |
| 3002.49 | Other | $589.9M | 6.7% | +30.7% | $45.7M |
| 3002.49.1000 | Toxins, toxoids, cryptotoxins and anti-toxins | $551.9M | 93.6% | +35.6% | $42.9M |
| 3002.49.2000 | Microbial culture | $8.8M | 1.5% | -13.9% | $943K |
| 3002.49.3000 | Virus and anti-virus | $59K | 0.0% | -92.5% | $9,142 |
| 3002.49.4000 | Other, including bacteriophage | $29.1M | 4.9% | -12.2% | $1.8M |
| 3002.51 | Cell therapy products | $1.0M | 0.0% | +1,749% | $0 |
| 3002.59 | Other | $4.2M | 0.0% | -21.7% | $24K |
| 3002.90 | Other | $57.7M | 0.7% | -34.5% | $5.0M |
| 3002.90.1000 | Human blood | $3.2M | 5.6% | +12.7% | $299K |
| 3002.90.2000 | Animal blood (prepared for therapeutic, prophylactic or diagnostic uses) | $129K | 0.2% | -35.2% | $9,380 |
| 3002.90.9000 | Other | $54.3M | 94.2% | -36.1% | $4.7M |
Six-digit codes are international; the indented ten-digit codes are South Korea's own subdivision. These rows are world totals; "Share" is the share of the row above.
Top destinations
Export value over the 12 months to October 2026. 184 countries received this product from South Korea in the last 24 months; the table shows the largest 20.
| Rank | Country | Exports, 12 months | Share | vs 12 months before | Rank before | October 2026 |
|---|---|---|---|---|---|---|
| 1 | Switzerland | $1.38B | 15.8% | +46.2% | 3 | $46.7M |
| 2 | United States | $1.38B | 15.7% | -22.4% | 1 | $118.7M |
| 3 | Hungary | $1.11B | 12.7% | +5.1% | 2 | $85.8M |
| 4 | Netherlands | $921.7M | 10.5% | +73.4% | 4 | $107.5M |
| 5 | Türkiye | $558.6M | 6.4% | +32.9% | 6 | $127.3M |
| 6 | Germany | $524.7M | 6.0% | +3.6% | 5 | $9.0M |
| 7 | Belgium | $373.9M | 4.3% | +155.7% | 10 | $34.0M |
| 8 | Italy | $370.4M | 4.2% | +30.6% | 7 | $28.2M |
| 9 | Japan | $336.1M | 3.8% | +47.1% | 8 | $24.7M |
| 10 | France | $231.8M | 2.6% | +216.6% | 14 | $4.8M |
| 11 | Brazil | $190.7M | 2.2% | -2.6% | 9 | $21.1M |
| 12 | Canada | $142.3M | 1.6% | +121.7% | 16 | $5.4M |
| 13 | China | $138.2M | 1.6% | +1.6% | 11 | $11.3M |
| 14 | Australia | $98.5M | 1.1% | +153.1% | 18 | $20.8M |
| 15 | Vietnam | $76.7M | 0.9% | +14.8% | 15 | $7.4M |
| 16 | Thailand | $61.8M | 0.7% | +8.3% | 17 | $4.1M |
| 17 | Saudi Arabia | $53.1M | 0.6% | +40.5% | 19 | $2.5M |
| 18 | United Kingdom | $50.6M | 0.6% | -37.4% | 12 | $427K |
| 19 | Ireland | $42.0M | 0.5% | +89.0% | 24 | $4.3M |
| 20 | Colombia | $37.1M | 0.4% | +38.6% | 21 | $5.0M |
Countries are linked when exports of this product to them reached $5,000,000 over 24 months.
Monthly figures
| Month | Exports | vs year earlier | Export weight | Export $/kg | Imports | Import weight |
|---|---|---|---|---|---|---|
| October 2026 | $730.6M | +32.9% | 540 t | $1,352.96 | $425.8M | 362 t |
| September 2026 | $673.3M | -14.4% | 536 t | $1,255.26 | $374.7M | 301 t |
| August 2026 | $690.8M | +24.8% | 369 t | $1,873.78 | $471.1M | 366 t |
| July 2026 | $712.0M | +52.9% | 450 t | $1,581.67 | $511.2M | 274 t |
| June 2026 | $1.02B | +20.3% | 599 t | $1,708.24 | $357.7M | 333 t |
| May 2026 | $707.6M | +10.2% | 419 t | $1,688.98 | $467.2M | 254 t |
| April 2026 | $822.1M | +27.2% | 485 t | $1,695.33 | $330.5M | 331 t |
| March 2026 | $654.4M | +1.8% | 411 t | $1,594.03 | $384.8M | 335 t |
| February 2026 | $687.1M | +24.1% | 350 t | $1,964.78 | $286.4M | 268 t |
| January 2026 | $659.2M | +11.5% | 437 t | $1,508.15 | $330.9M | 340 t |
| December 2025 | $663.1M | +43.0% | 470 t | $1,410.05 | $390.5M | 472 t |
| November 2025 | $738.4M | +9.9% | 464 t | $1,591.17 | $336.5M | 325 t |
| October 2025 | $549.7M | -2.3% | 413 t | $1,331.80 | $310.1M | 233 t |
| September 2025 | $786.6M | +38.1% | 435 t | $1,807.71 | $430.1M | 441 t |
| August 2025 | $553.6M | -14.7% | 427 t | $1,297.91 | $251.4M | 336 t |
| July 2025 | $465.6M | -11.5% | 341 t | $1,366.68 | $408.9M | 339 t |
| June 2025 | $850.3M | +67.2% | 431 t | $1,971.20 | $290.6M | 353 t |
| May 2025 | $642.1M | +14.6% | 391 t | $1,641.72 | $296.9M | 373 t |
| April 2025 | $646.1M | +18.2% | 435 t | $1,484.58 | $281.7M | 334 t |
| March 2025 | $643.1M | +19.6% | 461 t | $1,394.27 | $342.0M | 404 t |
| February 2025 | $553.7M | +13.1% | 417 t | $1,327.98 | $274.3M | 270 t |
| January 2025 | $591.1M | +29.2% | 356 t | $1,659.47 | $277.7M | 464 t |
| December 2024 | $463.8M | -10.3% | 391 t | $1,185.11 | $287.8M | 293 t |
| November 2024 | $671.9M | +50.0% | 428 t | $1,570.33 | $253.8M | 409 t |
Exports FOB, imports CIF, US dollars. Weight is net weight. "vs year earlier" compares export value with the same month one year before and is left blank when that month was under $10,000. Source: Korea Customs Service, via data.go.kr.